SCHEMBL5532677

SCHEMBL5532677

Cc1cc(=O)c(OCc2ccccc2)c2n1CCN(Cc1ccc(F)cc1)C2=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.51
LMNA P02545 5/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
NCOA3 Q9Y6Q9 1/20 0.50
HTT P42858 5/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
ALDH1A1 P00352 4/20 0.45
KCNH2 Q12809 2/20 0.43
GRM2 Q14416 2/20 0.43
HPGD P15428 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
TSHR P16473 2/20 0.41
USP2 O75604 1/20 0.41
CYP2C9 P11712 1/20 0.41
NPC1 O15118 1/20 0.40
NPSR1 Q6W5P4 2/20 0.40
GRM5 P41594 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4141251 0.83 SMN1; SMN2 (0.49) SMN1; SMN2LMNAL3MBTL1NCOA3HTT
SCHEMBL5529441 0.80 SMN1; SMN2 (0.56) SMN1; SMN2LMNAL3MBTL1NCOA3HTT
SCHEMBL4746430 0.79 SMN1; SMN2 (0.46) SMN1; SMN2LMNAL3MBTL1NCOA3HTT
SCHEMBL3982597 0.78 LMNA (0.44) SMN1; SMN2LMNAL3MBTL1NCOA3HTT
SCHEMBL3985585 0.77 LMNA (0.44) SMN1; SMN2LMNAL3MBTL1NCOA3HTT
SCHEMBL16180401 0.76 SCD (0.39) SMN1; SMN2LMNAL3MBTL1NCOA3HTT
SCHEMBL4744605 0.76 LMNA (0.45) SMN1; SMN2LMNAL3MBTL1NCOA3HTT
SCHEMBL3983664 0.76 LMNA (0.42) SMN1; SMN2LMNAL3MBTL1NCOA3HTT
SCHEMBL5531313 0.76 SCD (0.41) SMN1; SMN2LMNAL3MBTL1NCOA3MEN1
SCHEMBL4323891 0.75 SIGMAR1 (0.40) SMN1; SMN2LMNAL3MBTL1NCOA3HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070161639-A1 Hiv integrase inhibitors ISTITUTO DI RICHERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161639-A1 Hiv integrase inhibitors DPYD, DUT, TYMP SMN1; SMN2 3997/4885LMNA 2868/4885L3MBTL1 1226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.